Mutual Fund Details

Kotak Healthcare Fund Direct - Growth

Equity Pharma

NAV

₹14.2170

as on 24 Dec 2024, 10:44 PM

₹0.1050(0.74%)

Last Change

Schemes Managed By

Abhishek Bisen

Fund Manager

Shibani Sircar Kurian

Dhananjay Tikariha

Investment Performance

would have given a return of

₹1,03,499

₹1,06,749

₹1,38,502

₹1,40,827

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹40,827

Profit (absolute return)

40.83%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

0.69%

In the last 6 months

22.10%

In the last 1 year

40.83%

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Kotak Healthcare Fund Direct - Growth

as of 30 Nov 2024, 05:30 AM

₹418.74 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1%, if redeemed within 30 days.

0.74%

Expense Ratio

Plan

Growth

0.84%

Cash Holding

Benchmark

NIFTY Healthcare Total Return Index.

Scheme Document

View

Benchmark

NIFTY Healthcare Total Return Index.

Exit Load

Exit load of 1%, if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

99.16%

₹415.22 Cr

Others

0.84%

₹3.52 Cr

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

99.16%

₹415.22 Cr

Others

0.84%

₹3.52 Cr

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

15.02%

₹62.89 Cr

Cipla Ltd.

8.90%

₹37.27 Cr

Zydus Lifesciences Ltd.

6.25%

₹26.17 Cr

Max Healthcare Institute Ltd.

5.44%

₹22.78 Cr

Divi's Laboratories Ltd.

5.38%

₹22.53 Cr

Others

59.01%

₹247.10 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

15.02%

₹62.89 Cr

Cipla Ltd.

8.90%

₹37.27 Cr

Zydus Lifesciences Ltd.

6.25%

₹26.17 Cr

Max Healthcare Institute Ltd.

5.44%

₹22.78 Cr

Divi's Laboratories Ltd.

5.38%

₹22.53 Cr

Others

59.01%

₹247.10 Cr

View All

Funds in this Category

This fund's returns:

40.83%

Return Duration

1 Year

HDFC Pharma And Healthcare Fund Direct - Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

ITI Pharma and Healthcare Fund Direct - Growth

About Kotak Healthcare Fund Direct - Growth

Kotak Healthcare Fund Direct - Growth is a Equity mutual fund scheme from Kotak Mahindra Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund managers Abhishek Bisen, Shibani Sircar Kurian and Dhananjay Tikariha. It has an AUM of ₹418.74 Crores and the latest NAV decalared is ₹14.217 as on 26 Dec 2024 at 8:47 pm.

Kotak Healthcare Fund Direct - Growth scheme return performance in last 1 year is 40.83%, is 41.60% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.